Cardiology

Exclusive

Alcohol study failed to seek FDA approval, possibly violating federal rules

By Sharon Begley

Cardio Exam
Health

After malpractice caps, doctors ordered fewer invasive tests to diagnose heart attacks

By Elizabeth Cooney

Risk Calculator
Health

New risk calculator could change the aspirin, statins, and blood pressure medications some people take

By Elizabeth Cooney

Cholesterol
Biotech

A tiny biotech’s plot to frustrate Regeneron and Sanofi runs into a safety problem

By Damian Garde

Express Scripts flag
Biotech

Saddled with sluggish sales, Regeneron and Sanofi slash the cost of cholesterol-lowering drug

By Damian Garde

Victor Gurewich
In the Lab

At 88, this doctor won’t give up on a long-ignored treatment for strokes and heart attacks

By Karen Weintraub

STAT MADNESS
In the Lab

Rebuilding dying hearts: Meet the STAT Madness 2018 crowd favorite

By Elizabeth Cooney

Financial Meltdown Unemployment
Health

Another fallout from the Great Recession: Fewer people took their blood pressure and diabetes medications

By Kate Sheridan

Cholesterol
Biotech

Cholesterol drug significantly reduced patients’ risk of death in trial, a boon for Sanofi and Regeneron

By Damian Garde

EKG
Health

Watch: Webcast on heart and brain diseases in women

By STAT staff

In the Lab

It beats like the real thing, but can a miniature human heart prevent the next Vioxx?

By Sharon Begley

Cisplatin
Health

Heart group warns of cardiovascular risks after treatment for breast cancer

By Sharon Begley

Flu virus
Health

Flu infection raises risk of heart attack in week after diagnosis

By Helen Branswell

Embryonic stem cells
First Opinion

Stem cell clinics for heart failure: buyer be wary

By Paul J. Hauptman

Overdose vigil
Health

Life expectancy in the U.S. is falling — and drug overdose deaths are soaring

By Megan Thielking

Stethoscope exam
First Opinion

Cardiovascular disease: the next great challenge for HIV care

By Steven K. Grinspoon

Gold rush Miners
First Opinion

Big data often yields small returns. Here’s how to fix that

By Michael J. Pencina

Health

A study suggests women are less likely to get CPR from bystanders

By Associated Press

In the Lab

These fruit flies have a very human problem. Could they teach us about obesity?

By Rebecca Robbins

Michael Kent performing CT scan
Health

How beagles and goldens could help researchers find the next cancer therapy for humans

By Usha Lee McFarling

Cholesterol
Pharmalot

In a sign of tougher FDA enforcement, Aegerion pays hefty fine for illegal marketing

By Ed Silverman

Health

Former CDC director Tom Frieden to launch new global health initiative

By Helen Branswell

Obesity treatment
Health

Obesity, even without other risk factors, leads to higher rate of cardiovascular disease

By Kate Sheridan

In the Lab

Tantalizing clues point to inflammation’s role in an array of diseases. But will treatments follow?

By Meghana Keshavan

Fotolia
In the Lab

A welcome side effect: Novartis anti-inflammatory may cut risk of lung cancer, study finds

By Meghana Keshavan

Open heart surgery
Health

Newer method of open-heart surgery carries more risks, study finds

By Catherine Caruso

Heart Patch
In the Lab

This team is on the verge of creating a beating Band-Aid for the heart. Just don’t call it goopy

By Ike Swetlitz

Intravenous drips childhood cancer
Pharmalot

Dozens of hospitals slashed use of two key heart drugs after price hikes

By Ed Silverman

Heart cells
Biotech

MyoKardia drug improves blood flow in patients with serious, inherited form of heart disease

By Adam Feuerstein

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy